Incyte (INCY) Interest & Investment Income (2010 - 2026)
Incyte (INCY) reported Interest & Investment Income of $33.7 million for Q1 2026, up 46.92% on a YoY basis from $22.9 million in Q1 2025, and up 9.54% quarter-over-quarter from $30.8 million in Q4 2025.
Incyte (INCY) Interest & Investment Income (2010 - 2026) Analysis & Trends
Incyte has reported Interest & Investment Income for 11 years, with the latest figure at $33.7 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income rose 46.92% year-over-year to $33.7 million; the trailing twelve-month figure through Mar 2026 stood at $116.4 million (up 10.96% YoY), and the FY2025 full-year result was $105.6 million, down 17.96% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $33.7 million, up from $30.8 million in the prior quarter.
- The five-year high for Interest & Investment Income was $46.8 million in Q1 2024, with the low at $19.3 million in Q3 2024.
- Historically, Interest & Investment Income has averaged $29.8 million across 3 years, with a median of $26.8 million in 2025.
- Annual changes were most pronounced in 2025 — Interest & Investment Income slumped 50.97% — and 2026, when it soared 46.92%.
- Incyte's Interest & Investment Income stood at $21.2 million in 2024, then surged by 45.08% to $30.8 million in 2025, then gained by 9.54% to $33.7 million in 2026.
- The last three Interest & Investment Income figures came in at $33.7 million (Q1 2026), $30.8 million (Q4 2025), and $26.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Incyte | 19.62 Bn | 15.60 Bn | 1.17 Bn | 33.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.69 Mn |
| Dec 31, 2025 | 30.75 Mn |
| Sep 30, 2025 | 26.78 Mn |
| Jun 30, 2025 | 25.14 Mn |
| Mar 31, 2025 | 22.93 Mn |
| Dec 31, 2024 | 21.20 Mn |
| Sep 30, 2024 | 19.27 Mn |
| Jun 30, 2024 | 41.48 Mn |
| Mar 31, 2024 | 46.77 Mn |
| Dec 31, 2017 | 6.27 Mn |
| Sep 30, 2017 | 5.56 Mn |
| Jun 30, 2017 | 4.13 Mn |
| Mar 31, 2017 | 1.20 Mn |
| Dec 31, 2016 | 594,000.00 |
| Sep 30, 2016 | 1.19 Mn |
| Jun 30, 2016 | 1.14 Mn |
| Mar 31, 2016 | 1.49 Mn |
| Dec 31, 2015 | 1.29 Mn |
| Sep 30, 2015 | 3.03 Mn |
| Jun 30, 2015 | 1.14 Mn |